期刊文献+

血清t-PSA及f-PSA/t-PSA比值在前列腺癌诊断中的价值 被引量:3

Diagnostic value of serum t-PSA and f-PSA/t-PSA in prostate cancer
暂未订购
导出
摘要 目的探讨血清总前列腺特异性抗原(t-PSA)及游离前列腺特异性抗原(f-PSA)/t-PSA比值在前列腺癌(PCa)诊断中的价值。方法对96例PCa与50例前列腺增生(BPH)患者进行血清t-PSA、f-PSA检测并计算f-PSA/t-PSA比值。结果 PCa与BPH两组患者间t-PSA和f-PSA/t-PSA比值差异有统计学意义(P<0.05)。当t-PSA介于4.0~10.0ng/mL,两组患者间t-PSA差异无统计学意义(P>0.05),而f-PSA/t-PSA比值差异有统计学意义(P<0.05),而且f-PSA/t-PSA比值分别为0.10、0.16、0.25时,对PCa诊断的灵敏度分别为39.1%、67.3%、94.5%;特异性分别为92.5%、85.0%、52.4%。结论血清t-PSA及f-PSA/t-PSA比值在PCa诊断中有重要临床价值。 Objective To investigate the diagnostic value of serum t-PSA and f-PSA/t-PSA in prostate cancer(PCa).Methods Serum t-PSA and f-PSA/t-PSA of 96 patients with prostatic cancer and 50 patients with benign prostate hyperplasia(BPH) were measured simultaneously.Results The difference of t-PSA and f-PSA/t-PSA had statistical significance between PCa and BPH groups(P0.05).When the serum t-PSA was between 4.0-10.0 ng/mL,the difference had no statistical significance between PCa and BPH groups(P0.05),but f-PSA/t-PSA had statistical significance between PCa and BPH groups(P0.05).And when f-PSA/t-PSA was 0.10,0.16,0.25 respectively,the sensitivities for diagnosing PCa were 39.1%,67.3%,94.5% respectively,the specificities of them were 92.5%,85.0%,52.4% respectively.Conclusion The serum t-PSA and f-PSA/t-PSA have important clinical significances for the diagnosis of PCa.
机构地区 四川省肿瘤医院
出处 《检验医学与临床》 CAS 2012年第6期651-652,共2页 Laboratory Medicine and Clinic
关键词 前列腺癌 前列腺增生 前列腺特异性抗原 prostatic cancer benign prostate hyperplasia prostate specific antigen
  • 相关文献

参考文献8

二级参考文献32

  • 1丁芳,袁晓霞,聂娜.经阴道超声诊断早期异位妊娠86例分析[J].中国误诊学杂志,2009,9(1). 被引量:2
  • 2裴书文,雒向宁,侯俊明,张育军,蒋海波.经尿道前列腺电汽化治疗前列腺癌[J].实用诊断与治疗杂志,2005,19(8):584-585. 被引量:10
  • 3孙长成,孔垂泽,李泽良,杨春明.游离前列腺特异性抗原/总前列腺特异性抗原在前列腺癌诊断中的应用[J].中华泌尿外科杂志,2006,27(7):442-442. 被引量:4
  • 4梁朝朝,刘骋,唐智国,郝宗耀,武立新,叶元平,刘明,张贤生.前列腺增生住院患者10年回顾(附1345例报告)[J].中国男科学杂志,2007,21(4):5-8. 被引量:5
  • 5D'Amico,AV,叶雄俊(摘译),张小东(校).前列腺癌预防试验和非那雄胺:文献回顾[J].中华泌尿外科杂志,2007,28(5):360-360. 被引量:3
  • 6Jung K,Elgeti U,Lein M,et al.Ratio of free or complexed prostate-specific antigen (PSA) to total PSA:which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?[J].Clin Chem,2000,46 (1):55-62.
  • 7Etzioni R,Gulati R,Falcon S,et a1.Impact of PSA screening on the inddence of advanced stage prostate cancer in the United States:a surveillance modeling approach[J].Med Decis Making,2008,28:323.
  • 8Choi YD,Kang DR,Nam CM,et a1.Age specific prostate specific antigen reference ranges in Korean mell[J].Urology,2007,70(6):1113.
  • 9TANGUARY S,BEJIN L R,ELHILALI M M,et al.Comparative evaluation of total PSA,free/total PSA,and complexed PSA in prostate cancer detection[J].Urology,2002,59(2):261-265.
  • 10Morote J,Raventos CX,Lorente JA,et al.Comparison of percent free prostate specific an tigen and prostate specific antigen density as methods to enhance prostate specific antigen specif icity in early prostare cancer detection in men with normal rectal examination and prostare specif ic antigen between 4.1 and 10 ng/ml.J Urol,1997,158:502.

共引文献367

同被引文献26

  • 1Hao YZ,Li H J,Wang ZP. The prevalence of erectile dys-function and its relation to chronic prostatitis in Chinese men[J].{H}Journal of Andrology,2011,(5):496-501.
  • 2Liang CZ,Hao YZ,Li HJ. Prevalence of premature ejacu-lation and its correlation with chronic prostatitis in Chinese men[J].{H}UROLOGY,2010,(4):962-966.
  • 3Sabaliauskaite R,Jarmalaite S,Petroska D. Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer[J].{H}Genes Chromosomes & Cancer,2012,(8):781-791.
  • 4Stephan C,Bangrna C,Vignati G. 20%-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials-analysis of 1098patients in four centers[J].{H}International Journal of Biological Markers,2009,(2):65-69.
  • 5Shelley MD,Kumar S,Wilt T. A systematic review and meta-analysis of randomized trials of neo-adjuvant hormone therapy for localized and locally advanced prostate carcinoma[J].Can cer Treat Rev,2009,(1):9-17.
  • 6Vickers AJ,Cronin AM,Bjork T. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer:Case control study[J].{H}BMJ:British Medical Journal,2010.e4521.
  • 7Hankey BF,Feuer EJ,Clegg LX. Cancer surveillance series:interpreting trends in prostate cancer--part 1:Evidence of the effects of screening in recent prostate cancer incidence,mortality and survival rates[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1999,(12):1017-1024.
  • 8Stephan C,Bangrna C,Vignati G. 20%-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials-analysis of 1098 patients in four centers[J].{H}International Journal of Biological Markers,2009,(2):65-69.
  • 9Liang CZ,Li HJ,Wang ZP. The prevalence ofprostatitis-like symptoms in China[J].{H}Journal Of Urology,2009,(2):558-563.
  • 10Jemal A, Siegel R, Ward E, et al. Cancer statistics [ J ]. Cancer J Clin, 2009,59 (4) :225 - 249.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部